Comparing Myrbetriq vs Urispas
| Myrbetriq (mirabegron) | Urispas (flavoxate) |
|
|---|
| Myrbetriq (mirabegron) | Urispas (flavoxate) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Myrbetriq may be used to relieve symptoms of overactive bladder in adults such as urinary incontinence and urinary frequency. It may also be used to treat the symptoms of neurogenic detrusor... View more |
Prescription only
Prescribed for Urinary Frequency, Dysuria, Urinary Incontinence. Urispas may also be used for purposes not listed in this medication guide. |
Related suggestions Urinary Frequency
Urinary Incontinence
Popular comparisons
|
|||||||
| More about Myrbetriq (mirabegron) | More about Urispas (flavoxate) | ||||||||
| Ratings & Reviews | |||||||||
|
Myrbetriq has an average rating of 4.8 out of 10 from a total of 277 ratings on Drugs.com. 34% of reviewers reported a positive effect, while 49% reported a negative effect. |
Urispas has an average rating of 7.7 out of 10 from a total of 3 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 33% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Myrbetriq side effects |
View all Urispas side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Myrbetriq prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
N/A |
||||||||
| Brand Names | |||||||||
|
N/A |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
50 hours |
N/A |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 250 drugs are known to interact with Myrbetriq:
|
A total of 330 drugs are known to interact with Urispas:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
June 28, 2012 |
January 15, 1970 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.